Foundation-Array link up: targeting cancer responses
This article was originally published in Scrip
Executive Summary
Foundation Medicine Inc, a US molecular information company that has a single test that can provide a profile of a range of mutations in a tumour specimen, has linked up with Array BioPharma to combine its sequencing technology with Array's drug development programmes. Array has a portfolio of targeted cancer agents.